Health News of Alabama: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health News of Alabama.

Press releases published on October 30, 2026

9 hours ago

Werewolf Therapeutics Selected for Oral Presentation and to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 2026 Annual Meeting

Indeterminate GlobeNewswire

9 hours ago

Integra LifeSciences to Highlight Hands-On Education and Neurosurgery Innovation at CNS 2026 Annual Meeting

Indeterminate GlobeNewswire

9 hours ago

IRADIMED CORPORATION Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

9 hours ago

Sienna Completes Acquisition in Ottawa

Indeterminate GlobeNewswire

9 hours ago

Propanc Biopharma Advances Bioanalytical & Immunogenicity Assay Development for Phase 1b First-In-Human Study in up to 50 Advanced Cancer Patients

Indeterminate GlobeNewswire

9 hours ago

NurExone Demonstrates Consistent Anti-Inflammatory Activity Across Three Separate Batches of Exosomes

Indeterminate GlobeNewswire

9 hours ago

Polk County Mosquito Control Reduces Aedes aegypti by Up to 95% with Sterile Insect Farms™ Sterile Male Releases

Indeterminate GlobeNewswire

9 hours ago

Canon Medical and Stereotaxis Collaborate to Advance Robotic Electrophysiology

Indeterminate GlobeNewswire

9 hours ago

Aer Therapeutics Announces Top-Line Results from its Phase 2a Proof-of-Concept Trial of Fexlamose in Chronic Obstructive Pulmonary Disease (“COPD”)

Indeterminate GlobeNewswire

9 hours ago

Vor Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

9 hours ago

Profound Medical and Cook Medical’s iMRI Division Partner to Expand U.S. TULSA-PRO® Sales Channels and Drive Recurring Revenue Growth

Indeterminate GlobeNewswire

9 hours ago

Eos SENOLYTIX Reports Interim Data Showing Preserved Physical Function with MitoXcel Geropeptide PTC-2105 in a Second Species, Aged-Rat Study

Indeterminate GlobeNewswire

10 hours ago

Allarity Therapeutics Secures First Commercial Agreement Under New CLIA Laboratory Services Strategy, Establishing Potential Path to Additional Recurring Revenue

Indeterminate GlobeNewswire

10 hours ago

Braveheart Bio to Host Webinar – HCM Spotlight: Advancing a Next-Generation Cardiac Myosin Inhibitor – with Key Opinion Leader Discussion on November 6, 2026

Indeterminate GlobeNewswire

10 hours ago

Braveheart Bio Announces Upcoming Presentations at the American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire

10 hours ago

Alterity Therapeutics Releases Appendix 4C – Q1 FY27 Quarterly Cash Flow Report & Corporate Update

Indeterminate GlobeNewswire

10 hours ago

Syndax Announces Participation in November Investor Conferences

Indeterminate GlobeNewswire

10 hours ago

Acumen Pharmaceuticals Announces Topline Results from Phase 2 ALTITUDE-AD Clinical Trial of Sabirnetug (ACU193) for the Treatment of Early Alzheimer’s Disease; Trial Did Not Meet Primary Endpoint

Indeterminate GlobeNewswire

10 hours ago

NRx Pharmaceuticals (Nasdaq:NRXP) Receives FDA Approval of Preservative-Free Ketamine Ahead of November 10 FDA Goal Date

Indeterminate GlobeNewswire

10 hours ago

Fractyl Health Strengthens Revita Patent Portfolio as It Advances Toward FDA Submission and Potential Commercialization

Indeterminate GlobeNewswire